Exchange Traded Concepts, LLC Acadia Pharmaceuticals Inc Transaction History

Exchange Traded Concepts, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$14.2 - $18.63 $18,502 - $24,274	1,303 Added 33.1%	5,240 $83,000
Q3 2022 Oct 07, 2022	BUY	$14.11 - $18.27 $17,327 - $22,435	1,228 Added 45.33%	3,937 $64,000
Q2 2022 Jul 20, 2022	BUY	$13.01 - $27.22 $27,021 - $56,535	2,077 Added 328.64%	2,709 $38,000
Q1 2022 Apr 26, 2022	BUY	$20.94 - $27.5 $13,234 - $17,380	632 New	632 $15,000
Q2 2021 Jul 30, 2021	SELL	$19.4 - $27.42 $41,380 - $58,486	-2,133 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$25.02 - $54.99 $278,822 - $612,808	-11,144 Reduced 83.93%	2,133 $55,000
Q4 2020 Jan 19, 2021	SELL	$41.04 - $56.79 $125,089 - $173,095	-3,048 Reduced 18.67%	13,277 $710,000
Q3 2020 Oct 30, 2020	BUY	$36.42 - $57.0 $568,006 - $888,972	15,596 Added 2139.37%	16,325 $673,000
Q2 2020 Jul 15, 2020	SELL	$39.26 - $52.73 $6,124 - $8,225	-156 Reduced 17.63%	729 $35,000
Q1 2020 Apr 14, 2020	BUY	$31.65 - $46.87 $28,010 - $41,479	885 New	885 $37,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.